# Cerebrolysin

Cerebrolysin is a peptide preparation derived from pig brain. It is made by EVER Pharma (Austria). It contains small neuropeptides and free amino acids. It is marketed for your brain's recovery after ischemic stroke, traumatic brain injury, and vascular or Alzheimer's dementia. It is a prescription medicine in roughly 50 countries. (These include Austria, Germany, Russia, China, and several Central/Eastern European and Asian markets.) But it has no centralized EMA approval, and it is not FDA-approved. The evidence is weak. A Cochrane review on acute ischemic stroke (Ziganshina et al., 2017, updated 2023) found no clear clinical benefit. It also found a signal of more non-fatal serious adverse events. Meta-analyses in vascular dementia and TBI show small, inconsistent effects on cognitive scales. Using it as a longevity or anti-aging treatment is off-label, and not supported by current trial evidence.

## Sources

- Ziganshina LE, Abakumova T, Nurkhametova D, Ivanchenko K. (2023). Cerebrolysin for acute ischaemic stroke (updated review). Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD007026.pub7
- EVER Neuro Pharma GmbH. (2024). Cerebrolysin Summary of Product Characteristics (Austria, EVER Neuro Pharma). https://www.everpharma.com/aut/products/cerebrolysin/

---

_Canonical: https://longevity-germany.com/en/glossary/cerebrolysin · Part of Longevity Cities · Updated 2026-06-22_